Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
62
Number of overlapping holdings
18.0%
% of FHLC's 369 holdings also in XLV
100.0%
% of XLV's 62 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XLV |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 11.3% | 10.2% |
|
UNITEDHEALTH GROUP INC | 8.3% | 10.5% | 8.3% |
|
JOHNSON & JOHNSON | 6.1% | 7.1% | 6.1% |
|
ABBVIE INC | 5.2% | 5.6% | 5.2% |
|
MERCK & CO. INC. | 5.0% | 4.7% | 4.7% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to XLV
|
ALNYLAM PHARMACEUTICALS INC | 0.5% |
|
VEEVA SYSTEMS INC-CLASS A | 0.5% |
|
MODERNA, INC. | 0.4% |
|
ILLUMINA INC | 0.3% |
|
MERCK & CO. INC. | 0.3% |
|
REGENERON PHARMACEUTICALS | 0.3% |
|
AVANTOR, INC. | 0.3% |
|
BIOMARIN PHARMACEUTICAL INC | 0.2% |
|
UNITED THERAPEUTICS CORP | 0.2% |
|
NEUROCRINE BIOSCIENCES INC | 0.2% |
FHLC Underweight Relative to XLV
|
UNITEDHEALTH GROUP INC | -2.2% |
|
INTUITIVE SURGICAL INC | -1.1% |
|
ELI LILLY & CO | -1.1% |
|
JOHNSON & JOHNSON | -1.0% |
|
ABBOTT LABORATORIES | -1.0% |
|
STRYKER CORP | -0.8% |
|
BOSTON SCIENTIFIC CORP | -0.7% |
|
GILEAD SCIENCES INC | -0.6% |
|
BRISTOL-MYERS SQUIBB CO | -0.6% |
 |
MEDTRONIC PLC | -0.5% |